Delaware Business Court Insider
By Ellen Bardash | March 17, 2022
Moderna said in a statement Thursday that it plans to "vigorously defend" against other companies' attempts to claim credit and that its vaccine is a product of years of work on its own mRNA platform.
Delaware Business Court Insider | News
By Ellen Bardash | March 15, 2022
Following a five-day trial, the jury determined Texas-based Natera Inc. is liable for nine of the 10 false advertising claims brought by competitor CareDx Inc.
Delaware Business Court Insider | News
By Ellen Bardash | November 19, 2021
The shareholders suit said Emergent was in no position to produce millions of doses of the Johnson & Johnson and AstraZeneca COVID-19 vaccines.
Delaware Business Court Insider | News
By Ellen Bardash | October 14, 2021
It's the first time the court has had to analyze the merits of such a case at trial, though it reinforces what some Delaware practitioners have thought for years.
Delaware Business Court Insider | News
By Ellen Bardash | September 3, 2021
The case focuses not on a deal being made hastily but on allegations that the CEO of the biotech company now known as 180 Life Sciences Corp. knowingly failed to disclose millions of dollars in liability during its negotiation process last year.
Delaware Business Court Insider | News
By Ellen Bardash | July 28, 2021
Analysts and researchers quickly critiqued the Sorrento executives' claims, accusing them of using the pandemic as a springboard to capital needed to keep the company running.
Delaware Business Court Insider
By Ellen Bardash | June 24, 2021
The case stems from a contract between Macrophage Therapeutics Inc., represented by Richard, Layton & Finger, and Michael M. Goldberg, the CEO of Navidea Biopharmaceuticals Inc. who was supposed to become CEO of its subsidiary, Macrophage.
Delaware Business Court Insider | News
By Scott Graham | October 7, 2019
Making his first appearance before the Supreme Court, Irell's Morgan Chu argues that a provision referring to "expenses" isn't specific enough to force patent owners to pay the PTO's in-house attorneys fees.
Delaware Business Court Insider | News
By Tom McParland | June 14, 2019
Vice Chancellor Kathaleen S. McCormick ruled Thursday that plaintiff Thomas S. Howland Jr. and his Fox Rothschild attorneys had supported claims for breaches of fiduciary duty and unjust enrichment against the officers and directors of Anixa Biosciences Inc.
Delaware Business Court Insider | News
By Tom McParland | May 2, 2019
A Delaware federal judge on Thursday approved an agreement by San Francisco-based Genentech and Sandoz to dismiss the two entities, without prejudice, from the lawsuit, because neither had been involved in filing an abbreviated new drug application at the heart of the dispute.
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS